Frances R Levin, MD

Specialties:
Psychiatry, Addiction Psychiatry

More specialties

Profile Navigation

Overview
Schedule an Appointment
Location(s)
Credentials & Experience
Research

Overview

Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For over twenty years, she served as the Director of the Addiction Psychiatry Fellowship Program at New York-Presbyterian Hospital and for the past sixteen years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship which has been continuously funded since 1994. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. Subsequently, she graduated from a 2-year combined clinical and research fellowship at the University of Maryland and the Addiction Research Center, the intramural branch of the National Institute on Drug Abuse (NIDA). Currently, she serves as the Medical Director of the Providers’ Clinical Support System (PCSS), a SAMHSA-supported national training and mentoring initiative focused on addressing the opioid use disorder crisis. Also, she is the Medical Director of a SAMHSA-supported State Targeted Response technical assistance grant (the Opioid Response Network) to address the national opioid epidemic.
Dr. Levin, working with other senior faculty, inaugurated the university-wide Center for Healing of Opioid and Other Substance Use Disorders: Enhancing Intervention Development and Implementation (CHOSEN) in 2020 and serves as one of the senior Directors. Moreover, she is the principal investigator of several federal grants, including a K24 Mid-Career Investigator Award as well as a Co-Investigator on numerous other grants.
Her current research interests include pharmacologic and psychotherapeutic treatment interventions for opioid, cocaine and marijuana use disorders, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over two-hundred and fifty articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment, and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for eight years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is currently on the Board of Directors for the American Academy of Addiction Psychiatry (AAAP), the College on Drug Dependence (CPDD), and the American Society of ADHD and Related Disorders (APSARD). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry, and past Chair of the APA Council on Addiction Psychiatry.

Areas of Expertise / Conditions Treated

Addictive Disorders
Adult ADHD
Clinical Research
Substance Use

Academic Appointments

Kennedy-Leavy Professor of Psychiatry in the Division of Substance Abuse at CUMC

Hospital Affiliations

NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

Female

Schedule an Appointment

Phone Appointments

New and Existing Patients: (646) 774-6137

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Location(s)

CUIMC/Herbert Pardes Building of the New York State Psychiatric Institute
1051 Riverside Drive

New York, NY 10032

Primary

Phone: (646) 774-6137


Fax: (646) 774-6111



Open location in Google Maps

Credentials & Experience

Education & Training

Weill Cornell Medical College
Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Board Certifications

Psychiatry
Addiction Psychiatry

Honors & Awards

Dr. Levin is the recipient of the 2015 Founder's Award from the American Academy of Addiction Psychiatry and is an American Psychiatric Association Distinguished Fellow. She is a Best Doctor, New York Magazine in Addiction Psychiatry since 2011.



America's Top Doctor


NY Top Doctor

Research

Research Interests

Adult Attention Deficit-Hyperactivity Disorder (ADHD)
Psychiatric Comorbidity
Substance Use Disorders

Grants

RESEARCH FELLOWSHIP IN SUBSTANCE ABUSE DISORDER (Federal Gov)
Jul 1 2018 - Jun 30 2023
DOES MEDICAL CANNABIS REDUCE OPIOID ANALGESICS IN HIV+ AND HIV ADULTS WITH PAIN? (Federal Gov)
Jul 1 2017 - Jun 30 2022
COMBINING PREGABALIN WITH LOFEXIDINE: CAN IT INCREASE THE SUCCESS OF TRANSITION TO NALTREXONE? (Federal Gov)
Sep 30 2019 - Aug 31 2021
FY 2018 OPIOID STATE TARGETED RESPONSE TECHNICAL ASSISTANCE (STR TA) (Federal Gov)
Feb 1 2018 - Jan 31 2021
TRAINING MEDICAL AND DENTAL STUDENTS IN SBIRT (Federal Gov)
Sep 30 2015 - Sep 29 2019
PROVIDERS CLINICAL SUPPORT SYSTEM FOR MEDICATION ASSISTED TREATMENT (PCSS-MAT) - TRAINING AND IMPLEMENTATION (Federal Gov)
Aug 1 2016 - Jul 31 2019
A SEQUENCED BEHAVIORAL AND MEDICATION INTERVENTION FOR COCAINE DEPENDENCE (Federal Gov)
Jun 1 2014 - May 31 2019
PROVIDERS CLINICAL SUPPORT SYSTEM FOR OPIOID THERAPIES (Federal Gov)
Sep 30 2014 - Sep 29 2017
APA SAMHSA SUBSTANCE ABUSE MINORITY FELLOWSHIP (Private)
Jul 1 2016 - Jun 30 2017
SHARED PHARMACOTHERAPEUTIC STRATEGIES FOR CANNABINOID & OPIOID USE DISORDERS (Federal Gov)
Sep 1 2014 - Jun 30 2017
QUETIAPINE TREATMENT FOR CANNABIS DEPENDENCE (Federal Gov)
Aug 1 2012 - Aug 31 2016
IMPLEMENTING PHARMACOTHERAPIES FOR OPIOD DEPENDENCE: COLLABORATIVE STRATEGIES FOR TRAINING HEALTH PROFESSIONALS (Federal Gov)
Aug 1 2013 - Jul 31 2016
TRANSLATIONAL RESEARCH TRANINIG ON ADDICTION FOR RACIAL/ ETHNIC MINORITIES (Federal Gov)
Jun 15 2013 - Feb 28 2015
MULTI-SITE CONTROLLED TRIAL OF COCAINE VACCINE (6 OF 6) COLUMBIA UNIVERSITY SITE (Federal Gov)
Sep 15 2008 - Jul 31 2013
HUMAN COCAINE VACCINE (TA-CD) IN THE TREATMENT OF COCAINE DEPENDENCE (Federal Gov)
Oct 1 2010 - Sep 30 2012

Selected Publications

Nunes EV, Levin FR: Treatment of depression in patients with alcohol or drug dependence: A meta-analysis. JAMA 2004;291(15): 1887-1896
Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV: Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence 2011;116(1-3): 142-150
Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR: Extended-release mixed amphetamine sales and topiramate for cocaine dependence: A randomized controlled trial.. Biological Psychiatry 2012;72(11): 950-956
Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, Bisaga A, Sullivan MA, Carpenter KM: A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addictive Behaviors 2013;108(6): 1084-1094
Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J : Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2015;72(6): 593-602


For a complete list of publications, please visit PubMed.gov